Propafenone mono- and combined therapy effectiveness in prevention of recurrent atrial fibrillation paroxysms

1. ACC/AHH/ESC Guidelines for the Management of Patients With Atrial Fibrillation: Executive Summary//Europ. Heart. J. 2006; 27: 1979-2030.

2. Lau C.P., Chow M.S., Tse H.F., Tang M.O., Fan C. Control of paroxysmal atrial fibrillation recurrence using combined administration of propafenone and quinidine//Am J Cardiol 2000 Dec 15; 86(12): 1327-32.

3. Sarkozy A., Dorian P. Advances in the acute pharmacologic management of cardiac arrhythmias//Curr Cardiol Rep 2003 Sep; 5(5): 387-94.

4. Bunin Y., Anfalova L. Efficacy of propafenone as singl oral loading dose in pharmacology converting recent-onset atrial fibrillation end atrial flutter//Europace (supplements) 2005; 7: 121-22.

5. Naccarelli G.V. Wolbrette D.L., Khan M. et al. Old and new antiarrhythmic drugs for converting and maintaining sinus rhythm in atrial fibrillation: comparative efficacy and results of trials//Am J Cardiol 2003 Mar 20; 91(6A): 15D-26D.

6. Boriani G. Martignani C. Biffi M. et al. Oral loading with propafenone for conversion of recent-onset atrial fibrillation: a review on in-hospital treatment//Drugs 2002; 62(3): 415-23.

7. Hohnloser S.H., Li Y.G., Bender B. et al. Pharmacological management of atrial fibrillation: an update//J Cardiovasc Pharmacol Ther 2000 Jan; 5(1): 11-6.

8. Pacifico A. Henry P.D. Class I or class III agents for atrial fibrillation: are asking the right question?//Pacing Clin Electrophysiol 2003 Jul; 26(7 Pt 2): 1613-9.

9. Van Noord T., Van Gelder I.С., Crijns H.J. et al. How to enhance acute outcome of electrical cardioversion by drug therapy: importance of immediate reinitiation of atrial fibrillation//J Cardiovasc Electrophysiol 2002 Aug; 13(8): 822-5.

10. Bellandi F., Simonetti I., Leoncini M. et al. Long-term efficacy and safety of propafenone and sotalol for the maintenance of sinus rhythm after conversion of recurrent symptomatic atrial fibrillation//Am J Cardiol 2001 Sep 15; 88(6): 640-5.

11. Meinertz Т., Lip G.Y., Lombardi F. Efficacy and safety of propafenone sustained release in the prophylaxis of symptomatic paroxysmal atrial fibrillation (The European Rythmol/Rytmonorm Atrial Fibrillation Trial [ERAFT] Study)//Am J Cardiol 2002 Dec 15; 90(12): 1300-6.

12. Brembilla-Perrot B. Antiarrhythmic drugs in atrial fibrillation//Rev Prat. 2002. Jun 15; 52(12): 1317-23.

13. Lau C.P., Chow M.S., Tse H.E., Tang M.O., Fan С, Control of paroxysmal atrial fibrillation recurrence using combined administration of propafenone and quinidine//Am J Cardiol 2000 Dec 15; 86(12): 1327-32.

14. Tomcsanyi J., Somloi M. Patients admitted with atrial fibrillation to a regional hospital//Orv Hetil 2002 Sep 8; 143(36): 2073-6.

15. Семыкин В.Н., Бунин Ю.А., Федякина Л.Ф. Сравнительная эффективность комбинированной антиаритмической терапии пропафеноном, верапамилом и дилтиаземом пароксизмальной фибрилляции и трепетания предсердий.//Материалы VII Российского национального конгресса «Человек и лекарство». М., 2000. С 123-124.

16. Asensio-Lafuente E., Alvarez-Mosquera J.B., Lozano-Diaz J.E. et al. Atrial fibrillation. New views on an old disease//Gac Med Мех 2001, Sep-Oct; 137(5): 445-58.